1.Application of oral Gadovist in three-dimensional sampling perfection with application optimized contrasts using different flip angle evolutions MR cholangiopancreatography
Zidong ZHANG ; Peicai CAO ; Hongquan ZHAO ; Yufei CHEN
Journal of Practical Radiology 2024;40(6):998-1001
Objective To study the appropriate concentration of oral Gadovist solution for improving the image quality of three-dimensional sampling perfection with application optimized contrasts using different flip angle evolutions magnetic resonance cholangiopancreatography(3D-SPACE-MRCP).Methods In vitro experiments,0.05%,0.1%,0.15%and 0.2%Gadovist solution and direct drinking water were put into 100 mL plastic containers respectively for 3D-SPACE-MRCP scanning to measure the signal intensity(SI)of Gadovist solutions in each group.The concentration and the SI of Gadovist solution were analyzed with Spearman correlation,and one-way variance analysis was performed to compare the SI of different concentration Gadovist solutions.In clinical experiments,128 subjects were randomly divided into 4 groups,and then taken orally 300 mL of 0.05%,0.1%,0.15%and 0.2%Gadovist solutions respectively.The 3D-SPACE-MRCP scanning was performed,and the image quality was evaluated by two physicians and compared by one-way variance analysis.Results In vitro experiments,there was an extremely strong negative correlation between the concentration and the SI of Gadovist solution(r=-0.969,P<0.05),and there were significant differences in the SI among different concentrations of Gadovist solution(P<0.05).In clinical experiments,among the 26 cases with first-level images,24 cases were distributed in the 0.1%Gadovist solution group.There was a statistically significant difference in image quality of the 3D-SPACE-MRCP with different oral concentrations of Gadovist solution(F=89.57,P<0.05),however,there was no statistically significant difference between the 0.15%and the 0.2%Gadovist solution groups using the Tukey test(P>0.05).Conclusion Oral Gadovist solution can significantly improve the images quality of 3D-SPACE-MRCP,and 0.1%solution is the appropriate dilution concentration.
2.Study on the examination time of MR cholangiopancreatography after Gd-BOPTA enhancement
Zidong ZHANG ; Peicai CAO ; Hongquan ZHAO ; Wei CUI
Journal of Practical Radiology 2024;40(9):1541-1544
Objective To investigate the effect of magnetic resonance cholangiopancreatography(MRCP)after Gd-BOPTA enhancement to clearly show the pancreaticobiliary duct,and to explore the reasonable time of MRCP examination after enhance-ment.Methods The quality of MRCP images in 124 patients after Gd-BOPTA enhancement was retrospectively evaluated by two physicians.The interval time of MRCP examination from the beginning of arterial phase to MRCP acquisition was obtained from pic-ture archiving and communication system(PACS),and the relationship between the image quality grade of pancreaticobiliary duct and the interval time was analyzed by ANOVA.Then the reasonable examination time of MRCP was calculated.Results After Gd-BOPTA enhancement,there was a significant difference in the interval time between different grades of intrahepatic and extrahepatic bile ducts on MRCP images(P<0.05).The image quality of bile duct decreased with the increasing interval time,however,there was no sig-nificant difference in the interval time between different grades of pancreatic duct(P>0.05).The mean interval time of clear grade of intra-hepatic bile duct was(9.9±3.1)min,and the 95%confidence interval(CI)was 9.2-10.6 min.Conclusion The clarity of the bile ducts on MRCP is gradually decreased after Gd-BOPTA enhancement,while no change in that of the pancreatic duct.The MRCP examination should be completed within 10.6 min after the arterial phase beginning,which is of great significance for controlling image quality.
3.Efficacy of online problem management plus intervention for anxiety among adults in China: a randomized controlled study
Han ZHANG ; Caihong HU ; Jing CHEN ; Qian ZHAO ; Xiaofan ZHANG ; Renjie FENG ; Peicai FU ; Ye XIA ; Jie CAO ; Haihang YU ; Yuan YANG
Chinese Journal of Psychiatry 2023;56(1):24-31
Objective:To explore the efficacy of online problem management plus (PM+) intervention on the mental health among adults with anxiety.Methods:Ninety subjects with anxiety (Generalized Anxiety Disorder-7 (GAD-7) total score≥5) were enrolled and randomly allocated into either waiting group or online PM+group. Participants in the online PM+intervention group received online PM+intervention twice a week for 3 weeks, while participants in the waiting group received general psychological supports. Psychological evaluation was performed at the end of the 3-week treatment and at 6 months after treatment. Outcome measures included GAD-7, Patient Health Questionnaire -(PHQ-9), Patient Health Questionnaire-15 (PHQ-15), Perceived Stress Scale-14 (PSS-14), and Insomnia Severity Index (ISI). Two-factor repeated measure analysis of variance (ANOVA) was used to compare the scores of the two groups at baseline and after intervention. Single-factor repeated measure analysis of variance was used to compare the differences of scores at baseline,3-week post-intervention, and 6-month follow-up in the online PM+ group.Results:A total of 37 (37/45) pations in the online PM+intervention group and 30 (30/45) patients in the waiting group completed the psychological evaluation after intervention. After 3-week intervention, compared with baseline, no significant change was found in the scores of GAD-7 ( F=0.08, P=0.782), PHQ-9 ( F=0.33, P=0.570), PHQ-15 ( F=0.20, P=0.660), PSS-14 ( F=0.14, P=0.05) and ISI ( F=0.02, P=0.880) in the waiting group. The changes of GAD-7 ( F=22.61, P<0.001), PHQ-9 ( F=19.49, P<0.001), PHQ-15 ( F=12.67, P=0.001), PSS-14 ( F=16.69, P<0.001) and ISI ( F=5.59, P=0.022) scores in the online PM+group were statistically significant. There were significant differences in GAD-7 (9.7±5.2 vs. 5.0±3.5, F=17.11, P<0.001), PHQ-9 (11.4±5.9 vs. 6.9±4.7, F=11.65, P=0.002), PHQ-15 (10.4±5.4 vs. 6.3±4.1, F=12.24, P=0.002) and PSS-14 (26.0±7.5 vs.31.8±9.9, F=6.59, P=0.016) scale scores between the online PM+group and the waiting group after intervention. In addition, the scores of GAD-7 (95% CI=1.25-6.47, P=0.002) and PHQ-9 (95% CI=2.21-9.10, P=0.005) scales in the online PM+group still had statistically significant differences compared to the baseline at the 6-month follow-up. Conclusions:In this study, online PM+intervention significantly alleviated symptoms of anxiety, depression, somatization, stress, and insomnia in adults, and the therapeutic benefits of PM+persisted for at least 6 months.
4.Efficacy of online problem management plus intervention for anxiety among adults in China: a randomized controlled study
Han ZHANG ; Caihong HU ; Jing CHEN ; Qian ZHAO ; Xiaofan ZHANG ; Renjie FENG ; Peicai FU ; Ye XIA ; Jie CAO ; Haihang YU ; Yuan YANG
Chinese Journal of Psychiatry 2023;56(1):24-31
Objective:To explore the efficacy of online problem management plus (PM+) intervention on the mental health among adults with anxiety.Methods:Ninety subjects with anxiety (Generalized Anxiety Disorder-7 (GAD-7) total score≥5) were enrolled and randomly allocated into either waiting group or online PM+group. Participants in the online PM+intervention group received online PM+intervention twice a week for 3 weeks, while participants in the waiting group received general psychological supports. Psychological evaluation was performed at the end of the 3-week treatment and at 6 months after treatment. Outcome measures included GAD-7, Patient Health Questionnaire -(PHQ-9), Patient Health Questionnaire-15 (PHQ-15), Perceived Stress Scale-14 (PSS-14), and Insomnia Severity Index (ISI). Two-factor repeated measure analysis of variance (ANOVA) was used to compare the scores of the two groups at baseline and after intervention. Single-factor repeated measure analysis of variance was used to compare the differences of scores at baseline,3-week post-intervention, and 6-month follow-up in the online PM+ group.Results:A total of 37 (37/45) pations in the online PM+intervention group and 30 (30/45) patients in the waiting group completed the psychological evaluation after intervention. After 3-week intervention, compared with baseline, no significant change was found in the scores of GAD-7 ( F=0.08, P=0.782), PHQ-9 ( F=0.33, P=0.570), PHQ-15 ( F=0.20, P=0.660), PSS-14 ( F=0.14, P=0.05) and ISI ( F=0.02, P=0.880) in the waiting group. The changes of GAD-7 ( F=22.61, P<0.001), PHQ-9 ( F=19.49, P<0.001), PHQ-15 ( F=12.67, P=0.001), PSS-14 ( F=16.69, P<0.001) and ISI ( F=5.59, P=0.022) scores in the online PM+group were statistically significant. There were significant differences in GAD-7 (9.7±5.2 vs. 5.0±3.5, F=17.11, P<0.001), PHQ-9 (11.4±5.9 vs. 6.9±4.7, F=11.65, P=0.002), PHQ-15 (10.4±5.4 vs. 6.3±4.1, F=12.24, P=0.002) and PSS-14 (26.0±7.5 vs.31.8±9.9, F=6.59, P=0.016) scale scores between the online PM+group and the waiting group after intervention. In addition, the scores of GAD-7 (95% CI=1.25-6.47, P=0.002) and PHQ-9 (95% CI=2.21-9.10, P=0.005) scales in the online PM+group still had statistically significant differences compared to the baseline at the 6-month follow-up. Conclusions:In this study, online PM+intervention significantly alleviated symptoms of anxiety, depression, somatization, stress, and insomnia in adults, and the therapeutic benefits of PM+persisted for at least 6 months.

Result Analysis
Print
Save
E-mail